Compare IDEXX Laboratories, Inc. (IDXX) vs PulteGroup, Inc. (PHM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs PulteGroup, Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $571 (market cap $46.22B), while PulteGroup, Inc. trades at $129.46 (market cap $25.22B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and PulteGroup, Inc. pays a 0.79% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | PHM | |
|---|---|---|
Market Cap | $46.22B | $25.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $142.56 |
52-Week Low | $526.44 | $110.11 |
Enterprise Value | $47.12B | $25.64B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
PulteGroup (PHM) trades at $129.35, down 0.54% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q2 2026 EPS of $2.48, beating estimates, but revenue and margins face pressure. Analyst consensus is a Moderate Buy with a $137.20 price target, and recent news highlights operational expansion into Northwest Florida and workplace recognition.
The outlook remains cautiously optimistic supported by a solid balance sheet and community growth, though margin compression and housing market affordability challenges present near-term risks. The stock offers value with a P/E of 13.53, but investors should monitor earnings consistency and industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →
